MCL coexpression mm9:3247
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr1:174204455..174204475,- | p@chr1:174204455..174204475 - |
Mm9::chr1:174228120..174228139,- | p1@Atp1a2 |
Mm9::chr2:71205623..71205634,- | p2@Slc25a12 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0051481 | reduction of cytosolic calcium ion concentration | 0.00849152215471345 |
GO:0045988 | negative regulation of striated muscle contraction | 0.00849152215471345 |
GO:0043490 | malate-aspartate shuttle | 0.00849152215471345 |
GO:0006942 | regulation of striated muscle contraction | 0.00849152215471345 |
GO:0002087 | neurological control of breathing | 0.0101895474352689 |
GO:0003016 | respiratory system process | 0.012735887480134 |
GO:0045932 | negative regulation of muscle contraction | 0.012735887480134 |
GO:0045822 | negative regulation of heart contraction | 0.012735887480134 |
GO:0001504 | neurotransmitter uptake | 0.0132072251548221 |
GO:0019229 | regulation of vasoconstriction | 0.0135842022444435 |
GO:0005391 | sodium:potassium-exchanging ATPase activity | 0.0154357475493305 |
GO:0002026 | regulation of the force of heart contraction | 0.0183927537650214 |
GO:0042310 | vasoconstriction | 0.0206137938818341 |
GO:0006940 | regulation of smooth muscle contraction | 0.0206137938818341 |
GO:0051480 | cytosolic calcium ion homeostasis | 0.0215018377280429 |
GO:0007632 | visual behavior | 0.0219660155602007 |
GO:0008542 | visual learning | 0.0219660155602007 |
GO:0006939 | smooth muscle contraction | 0.0230766925527323 |
GO:0042383 | sarcolemma | 0.0230766925527323 |
GO:0051241 | negative regulation of multicellular organismal process | 0.0230766925527323 |
GO:0006941 | striated muscle contraction | 0.0230766925527323 |
GO:0006937 | regulation of muscle contraction | 0.0230766925527323 |
GO:0003018 | vascular process in circulatory system | 0.0230766925527323 |
GO:0035150 | regulation of tube size | 0.0230766925527323 |
GO:0050880 | regulation of blood vessel size | 0.0230766925527323 |
GO:0008016 | regulation of heart contraction | 0.0234930818595918 |
GO:0008217 | regulation of blood pressure | 0.0248798055474021 |
GO:0008344 | adult locomotory behavior | 0.0248798055474021 |
GO:0003015 | heart process | 0.0248798055474021 |
GO:0060047 | heart contraction | 0.0248798055474021 |
GO:0006836 | neurotransmitter transport | 0.025971803091423 |
GO:0007612 | learning | 0.025971803091423 |
GO:0006874 | cellular calcium ion homeostasis | 0.0287303129389502 |
GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism | 0.0287303129389502 |
GO:0055074 | calcium ion homeostasis | 0.0287303129389502 |
GO:0030534 | adult behavior | 0.0287303129389502 |
GO:0006875 | cellular metal ion homeostasis | 0.0295579222601135 |
GO:0055065 | metal ion homeostasis | 0.0295579222601135 |
GO:0007611 | learning and/or memory | 0.0295579222601135 |
GO:0009416 | response to light stimulus | 0.030933771012325 |
GO:0031402 | sodium ion binding | 0.0319651090362122 |
GO:0042625 | ATPase activity, coupled to transmembrane movement of ions | 0.0319651090362122 |
GO:0003012 | muscle system process | 0.0319651090362122 |
GO:0006936 | muscle contraction | 0.0319651090362122 |
GO:0001505 | regulation of neurotransmitter levels | 0.0325234766376159 |
GO:0009314 | response to radiation | 0.0325234766376159 |
GO:0008015 | blood circulation | 0.0325234766376159 |
GO:0003013 | circulatory system process | 0.0325234766376159 |
GO:0030005 | cellular di-, tri-valent inorganic cation homeostasis | 0.0325234766376159 |
GO:0015077 | monovalent inorganic cation transmembrane transporter activity | 0.0325234766376159 |
GO:0055066 | di-, tri-valent inorganic cation homeostasis | 0.0325482600833689 |
GO:0030003 | cellular cation homeostasis | 0.0338600114717001 |
GO:0055080 | cation homeostasis | 0.0338600114717001 |
GO:0030955 | potassium ion binding | 0.0338600114717001 |
GO:0006814 | sodium ion transport | 0.0338600114717001 |
GO:0043492 | ATPase activity, coupled to movement of substances | 0.0338600114717001 |
GO:0042626 | ATPase activity, coupled to transmembrane movement of substances | 0.0338600114717001 |
GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances | 0.0338600114717001 |
GO:0015399 | primary active transmembrane transporter activity | 0.036105435153291 |
GO:0015405 | P-P-bond-hydrolysis-driven transmembrane transporter activity | 0.036105435153291 |
GO:0022890 | inorganic cation transmembrane transporter activity | 0.0363428939980021 |
GO:0006810 | transport | 0.0379308700280174 |
GO:0055082 | cellular chemical homeostasis | 0.0379308700280174 |
GO:0006873 | cellular ion homeostasis | 0.0379308700280174 |
GO:0051234 | establishment of localization | 0.0379308700280174 |
GO:0035239 | tube morphogenesis | 0.0379308700280174 |
GO:0005792 | microsome | 0.0380537807894322 |
GO:0006813 | potassium ion transport | 0.0380537807894322 |
GO:0042598 | vesicular fraction | 0.0384784939438254 |
GO:0050801 | ion homeostasis | 0.040002486394148 |
GO:0009628 | response to abiotic stimulus | 0.040002486394148 |
GO:0031420 | alkali metal ion binding | 0.0415498292225967 |
GO:0051179 | localization | 0.0433805360234735 |
GO:0007268 | synaptic transmission | 0.0433805360234735 |
GO:0035295 | tube development | 0.0448918266372321 |
GO:0007626 | locomotory behavior | 0.0448918266372321 |
GO:0048878 | chemical homeostasis | 0.0456173786585225 |
GO:0019725 | cellular homeostasis | 0.0456782725779116 |
GO:0042623 | ATPase activity, coupled | 0.0474730127310945 |
GO:0019226 | transmission of nerve impulse | 0.0474730127310945 |
GO:0005743 | mitochondrial inner membrane | 0.0477152101550416 |
GO:0019866 | organelle inner membrane | 0.0489735652120997 |
Relative expression of the co-expression cluster over median <br>Analyst:
"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |